Innovation and Industry Strength Recognized at CPhI

Published on: 
BioPharm International, BioPharm International-11-01-2018, Volume 31, Issue 11
Pages: 6

Survey results and record attendance may show positive signs for established and emerging biopharma regions.

Using the annual CPhI Worldwide tradeshow as a benchmark, the bio/pharma industry appears to be healthy and growing. Organizers of the 2018 event, held Oct. 9–11 in Madrid, Spain, reported attendance has increased by 9000 attendees compared with the last CPhI event in Madrid in 2015. Nearly 44,500 participants from 164 countries visited the event, which included more than 2500 exhibits, conference sessions, and networking opportunities (1).

Opinions about industry prospects around the globe also were revealed. In an annual study released during the event (2), CPhI reported results of a survey of bio/pharma professionals that ranked India, the United States, and China as the top regions for predicted pharma market growth. The US ranked first of 10 countries evaluated for reputation, followed by Germany, Japan, the United Kingdom, and France. India was ranked sixth; China was ranked last.

CPhI also measured perceptions of the knowledge of bioprocessing professionals, innovation, and quality with the US ranking first, followed again by Germany, Japan, and the UK. In a measure of growth potential, Ireland-home to planned expansions of bioprocessing capacity-ranked third.

Recognizing innovation

In addition to the industry data, innovative technologies and services that support bio/pharma development, manufacturing, and distribution were recognized at the 2018 CPhI Pharma Awards Gala, held on Oct. 9, 2018. The winners are as follows:


  • Bioprocessing and Manufacturing-Merck, Simplification of Fed Batch Processes Using Modified Amino Acids

  • API Development-Ipca Labs Limited, Atemisinin Formulation-MiVital AG, Micelle Inside Solubilization Excipients-Merck, Parteck MXP Excipient

  • Manufacturing Technology and Equipment-AqVida GmbH, AqVida filling line

  • Analysis, Testing, and Quality Control-Tornado Spectral Systems, HyperFlux PRO Plus, Tornado Spectral Systems

  • Drug Delivery Devices-Nemera, e-NOVELIA, a smart ophthalmic add-on. Highly commended: Stiplastics, Stiplastics

  • Packaging-Technoflex, Dual-Mix. Highly commended: Aptar Pharma, QuickFlip

  • Supply Chain, Logistics, and Distribution-Systech International, UniSecure

  • Contract Services and Outsourcing-CatSci Ltd, Development of a novel bio-catalyzed manufacturing route for a generic API. Highly commended: Cambrex, Continuous Flow Centre of Excellence

  • Regulatory Procedures and

  • Corporate Social Responsibility-West Pharmaceutical Services, Inc., Delivering on the Promise of Good Corporate Citizenship

  • CEO of the Year-Nanobiotix, Laurent Levy

  • Pharma Company of the Year-Nanobiotix

  • OTC-Medical Brands and Vemedia, Excilor 2-in-1 Wart Treatment Device

  • Patient Centricity-SRS Life Sciences Pte Ltd, SRS Unistraw Delivery System

  • IT, mHealth, and Digitalization-Qualit-e Cloud GmbH, Qualit-e Cloud

CPhI and BioPharm International are UBM plc, a part of Informa brands.


1. CPhI, “Global Pharma Set for Strong Year with Record 164 Countries and 44,500 Attendees at CPhI Worldwide,” Press Release, Oct. 22, 2018.
2. CPhI, “CPhI’s Pharma Industry Rankings: A Snapshot of Pharma’s Health,” CPhI Annual Industry Report, October 2018.

Article Details

BioPharm International
Vol. 31, No. 11
November 2018
Page: 6


When referring to this article, please cite it as R. Peters, " Innovation and Industry Strength Recognized at CPhI," BioPharm International 31 (11) 2018.